Corporate Tech Investors

Mitsui & Co.

Mitsui & Co. is a corporate VC investing group that invests in companies that are a good strategic fit.

Venture Investor Overview

Venture Investor
Mitsui & Co.
Status
Active
Investor Type
Corporate
Activity Level
81 transaction
Funds Raised
Unknown
Industry Focus
Biopharmaceutical
Clean Tech
Communications
Energy & Battery
Engineering
FinTech
FoodTech
Healthcare IT
Life Sciences
Software
Transportation

Contact Information

Contact
Tatsuo Yasunaga
Title
Chief Executive Officer
Mailing Address
1-3 Marunouchi 1-chome Chiyoda-ku
Tokyo, 100-8631
Japan
Phone
+81(3) 3285-1111
Website
www.Mitsui.com
Email Address
Not Recorded

Background Information

Overview
The history of the Mitsui Group is a fascinating saga extending back well over three centuries, when Takatoshi Mitsui founded a kimono store in Edo, a city which later developed and expanded to become present day Tokyo. Over the years, Mitsui expanded to become a major commercial enterprise trading in Japan and overseas.
Profile
Mitsui & Co. LinkedIn Company Profile
Social Media
Mitsui & Co. Company Twitter Account
Company News
Mitsui & Co. News
Facebook
Mitsui & Co. on Facebook
YouTube
Mitsui & Co. on YouTube
Last Transaction
12/12/2024

Transaction History

Our records indicate that Mitsui & Co. invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
one.bio
12/12/2024
$27,000,000
Heirloom Carbon Technologies
12/4/2024
$150,000,000
Numa
10/1/2024
$32,000,000
ProofPilot
7/11/2024
Unknown
Firefly Aerospace
11/13/2023
$300,000,000
Lokavant
10/5/2023
$8,000,000
Kyoto Fusioneering
5/17/2023
$79,000,000
The Mobility House
11/3/2022
$50,000,000
FourKites
9/27/2022
$10,000,000
Atlas Space Operations
8/25/2022
$26,000,000
Bearing
8/17/2022
$7,000,000
ENSEM Therapeutics
4/6/2022
$67,000,000
Terra Drone
3/23/2022
$70,000,000
Kyash
3/17/2022
$41,200,000
LanzaTech
6/4/2020
$50,000,000
Rallybio
5/20/2020
$145,000,000
Advano
1/29/2020
$18,500,000
Arcadia
12/11/2019
$30,000,000
EV Connect
10/23/2019
$12,000,000
TriNetX
3/14/2019
$40,000,000
Fictiv
3/6/2019
$33,000,000
NapaJen Pharma
1/10/2019
$12,400,000
RideCell
11/14/2018
$31,390,000
Whill
9/19/2018
$45,000,000
RideCell
6/1/2018
$28,610,000
Spaceflight Industries
3/15/2018
$150,000,000
Element Analytics
1/9/2018
$19,500,000
C Squared
5/19/2017
$100,000,000
Calysta
5/2/2017
$40,000,000
Autotalks
3/23/2017
$30,000,000
PeerSpace
3/8/2017
$11,000,000
CounterTack
11/2/2016
$10,000,000
MetroMile
9/22/2016
$191,500,000
Ayla Networks
6/27/2016
$39,000,000
Black Swan
3/23/2016
$4,300,000
Mercari
3/3/2016
$75,000,000
Team8
2/24/2016
$23,000,000
Farmers Edge
1/27/2016
$41,000,000
Phytech
12/28/2015
Unknown
GNS Healthcare
12/8/2015
$10,000,000
Kabuku
11/26/2015
$6,100,000
WellAware
9/1/2015
$16,000,000
PipelineRx
7/7/2015
$9,100,000
CounterTack
6/2/2015
$17,935,732
Sirrus
2/20/2015
$6,621,688
Symic Biomedical
1/5/2015
$15,000,000
Kaminario
12/2/2014
$53,000,000
DocuSign
10/6/2014
Unknown
Spire
7/29/2014
$25,000,000
Synergis Education
5/14/2014
$5,000,000
Pinnacle Engines
5/8/2014
Unknown
SCIenergy
4/1/2014
$12,000,000
LanzaTech
3/26/2014
$60,000,000
Kaltura
2/11/2014
$47,000,000
GNS Healthcare
12/30/2013
$9,939,920
Box
12/5/2013
$100,000,000
Axeda
8/21/2013
$12,000,000
Change Healthcare
8/13/2013
$15,000,000
Rive Technology
8/1/2013
$20,000,000
NX Pharmagen Technologies
12/3/2012
$17,000,000
Sopogy
11/28/2012
Unknown
Edison Pharmaceuticals
11/27/2012
$20,000,000
Kaltura
11/20/2012
$25,000,000
Kaminario
9/25/2012
Unknown
ContinuumRx
9/21/2012
$7,000,000
Virident Systems
9/18/2012
$26,000,000
Viridity Energy
8/8/2012
$15,000,000
Redwood Systems
5/30/2012
$11,750,000
BioAmber
2/23/2012
$30,000,000
EnerVault
2/23/2012
$15,500,000
eyeSight
11/22/2011
$4,200,000
Prudent Energy
10/12/2011
$29,500,000
Valens Semiconductor
7/6/2011
$14,000,000
Proterra
6/13/2011
$30,000,000
Marrone Bio Innovations
6/2/2011
$25,400,000
OpenX Software
5/31/2011
$20,000,000
BioAmber
5/4/2011
$45,000,000
Cylene Pharmaceuticals
9/27/2010
$12,000,000
Lens Vector
2/4/2010
$30,000,000
BioAmber
10/27/2009
$12,000,000
Beceem Communications
4/22/2009
$20,000,000

 

Investor Contacts

Title
Name
Email & Social
Chief Executive Officer
Tatsuo Yasunaga
  Tatsuo Yasunaga LinkedIn Profile  Tatsuo Yasunaga Twitter Account  Tatsuo Yasunaga News  Tatsuo Yasunaga on Facebook

 

Funds

No fund closings have been recorded for this company.

 

Portfolio Companies

Mitsui & Co. has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
Advano
Arcadia
Atlas Space Operations
Autotalks
Axeda
Ayla Networks
Bearing
Beceem Communications
BioAmber
Black Swan
Box
C Squared
Calysta
Change Healthcare
ContinuumRx
CounterTack
Cylene Pharmaceuticals
DocuSign
Edison Pharmaceuticals
Element Analytics
EnerVault
ENSEM Therapeutics
EV Connect
eyeSight
Farmers Edge
Fictiv
Firefly Aerospace
FourKites
GNS Healthcare
Heirloom Carbon Technologies
Kabuku
Kaltura
Kaminario
Kyash
Kyoto Fusioneering
LanzaTech
Lens Vector
Lokavant
Marrone Bio Innovations
Mercari
MetroMile
NapaJen Pharma
Numa
NX Pharmagen Technologies
one.bio
OpenX Software
PeerSpace
Phytech
Pinnacle Engines
PipelineRx
ProofPilot
Proterra
Prudent Energy
Rallybio
Redwood Systems
RideCell
Rive Technology
SCIenergy
Sirrus
Sopogy
Spaceflight Industries
Spire
Symic Biomedical
Synergis Education
Team8
Terra Drone
The Mobility House
TriNetX
Valens Semiconductor
Virident Systems
Viridity Energy
WellAware
Whill

 

 

 

 

Browse more corporate investors:

Mitsubishi Corporation | Mitsui & Co. Venture Partners

 

Share this article

 

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.